Compare NCMI & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NCMI | MASS |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 306.0M | 251.9M |
| IPO Year | 2006 | 2020 |
| Metric | NCMI | MASS |
|---|---|---|
| Price | $3.40 | $6.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.63 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 420.0K | 228.0K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.36% | N/A |
| EPS Growth | 52.17 | ★ 125.47 |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $56,197,000.00 |
| Revenue This Year | $11.20 | $19.44 |
| Revenue Next Year | $6.22 | $18.63 |
| P/E Ratio | ★ N/A | $12.61 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.92 | $4.20 |
| 52 Week High | $5.88 | $9.34 |
| Indicator | NCMI | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 47.03 | 45.24 |
| Support Level | $3.17 | $5.86 |
| Resistance Level | $3.77 | $6.66 |
| Average True Range (ATR) | 0.13 | 0.35 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 9.72 | 13.24 |
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show and the CineLife Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.